405 related articles for article (PubMed ID: 19727127)
1. Contribution of bone microenvironment to leukemogenesis and leukemia progression.
Ayala F; Dewar R; Kieran M; Kalluri R
Leukemia; 2009 Dec; 23(12):2233-41. PubMed ID: 19727127
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic alteration of bone marrow HSC and microenvironmental association in experimentally induced leukemia.
Basak P; Chatterjee S; Das M; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
Curr Stem Cell Res Ther; 2010 Dec; 5(4):379-86. PubMed ID: 20528754
[TBL] [Abstract][Full Text] [Related]
3. Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.
Cho BS; Kim HJ; Konopleva M
Korean J Intern Med; 2017 Mar; 32(2):248-257. PubMed ID: 28219003
[TBL] [Abstract][Full Text] [Related]
4. Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia.
Litwin C; Leong KG; Zapf R; Sutherland H; Naiman SC; Karsan A
Am J Hematol; 2002 May; 70(1):22-30. PubMed ID: 11994978
[TBL] [Abstract][Full Text] [Related]
5. The bone marrow microenvironment - Home of the leukemic blasts.
Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
[TBL] [Abstract][Full Text] [Related]
6. Angiopoietins in the bone marrow microenvironment of acute lymphoblastic leukemia.
Karakurt N; Aksu T; Koksal Y; Yarali N; Tunc B; Uckan-Cetinkaya D; Ozguner M
Hematology; 2016 Jul; 21(6):325-31. PubMed ID: 26901808
[TBL] [Abstract][Full Text] [Related]
7. Leukemic stromal hematopoietic microenvironment negatively regulates the normal hematopoiesis in mouse model of leukemia.
Basak P; Chatterjee S; Das P; Das M; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
Chin J Cancer; 2010 Dec; 29(12):969-79. PubMed ID: 21114916
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
[TBL] [Abstract][Full Text] [Related]
9. "Caught in the net": the extracellular matrix of the bone marrow in normal hematopoiesis and leukemia.
Zanetti C; Krause DS
Exp Hematol; 2020 Sep; 89():13-25. PubMed ID: 32755619
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
[TBL] [Abstract][Full Text] [Related]
11. ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells.
Portale F; Cricrì G; Bresolin S; Lupi M; Gaspari S; Silvestri D; Russo B; Marino N; Ubezio P; Pagni F; Vergani P; Kronnie GT; Valsecchi MG; Locatelli F; Rizzari C; Biondi A; Dander E; D'Amico G
Haematologica; 2019 Mar; 104(3):533-545. PubMed ID: 30262563
[TBL] [Abstract][Full Text] [Related]
12. Targeting the leukemia microenvironment.
Konopleva M; Andreeff M
Curr Drug Targets; 2007 Jun; 8(6):685-701. PubMed ID: 17584025
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic targeting of microenvironmental interactions in leukemia: mechanisms and approaches.
Konopleva M; Tabe Y; Zeng Z; Andreeff M
Drug Resist Updat; 2009; 12(4-5):103-13. PubMed ID: 19632887
[TBL] [Abstract][Full Text] [Related]
14. Microenvironmental remodeling as a parameter and prognostic factor of heterogeneous leukemogenesis in acute myelogenous leukemia.
Kim JA; Shim JS; Lee GY; Yim HW; Kim TM; Kim M; Leem SH; Lee JW; Min CK; Oh IH
Cancer Res; 2015 Jun; 75(11):2222-31. PubMed ID: 25791383
[TBL] [Abstract][Full Text] [Related]
15. The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt Leukemia.
Dander E; Palmi C; D'Amico G; Cazzaniga G
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922612
[TBL] [Abstract][Full Text] [Related]
16. COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems.
Katoh H; Hosono K; Ito Y; Suzuki T; Ogawa Y; Kubo H; Kamata H; Mishima T; Tamaki H; Sakagami H; Sugimoto Y; Narumiya S; Watanabe M; Majima M
Am J Pathol; 2010 Mar; 176(3):1469-83. PubMed ID: 20110411
[TBL] [Abstract][Full Text] [Related]
17. Dependence of acute myeloid leukemia on adhesion within the bone marrow microenvironment.
Becker PS
ScientificWorldJournal; 2012; 2012():856467. PubMed ID: 22346731
[TBL] [Abstract][Full Text] [Related]
18. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
[TBL] [Abstract][Full Text] [Related]
19. A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment.
Han AR; Lee JY; Kim HJ; Min WS; Park G; Kim SH
Oncol Rep; 2015 Dec; 34(6):2880-8. PubMed ID: 26398122
[TBL] [Abstract][Full Text] [Related]
20. Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease.
Bradstock KF; Gottlieb DJ
Leuk Lymphoma; 1995 Jun; 18(1-2):1-16. PubMed ID: 8580810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
